Shanghai INT Medical Instruments Future Growth
Future criteria checks 5/6
Shanghai INT Medical Instruments is forecast to grow earnings and revenue by 27.2% and 28.7% per annum respectively. EPS is expected to grow by 26.4% per annum. Return on equity is forecast to be 14.7% in 3 years.
Key information
27.2%
Earnings growth rate
26.4%
EPS growth rate
Medical Equipment earnings growth | 34.5% |
Revenue growth rate | 28.7% |
Future return on equity | 14.7% |
Analyst coverage | Low |
Last updated | 19 Mar 2024 |
Recent future growth updates
No updates
Recent updates
Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital
Jul 14Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year
May 17Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture
Nov 26Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return
Aug 16Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital
Apr 24Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield
Apr 05What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?
Mar 15Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?
Jan 28Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today
Dec 28Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?
Dec 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,664 | 331 | 221 | N/A | 1 |
12/31/2025 | 1,282 | 260 | 160 | N/A | 1 |
12/31/2024 | 979 | 199 | 46 | N/A | 1 |
6/30/2024 | 805 | 167 | N/A | N/A | N/A |
3/31/2024 | 779 | 160 | N/A | N/A | N/A |
12/31/2023 | 753 | 152 | -53 | 178 | N/A |
9/30/2023 | 727 | 156 | -101 | 175 | N/A |
6/30/2023 | 700 | 161 | -149 | 172 | N/A |
3/31/2023 | 643 | 147 | -128 | 176 | N/A |
12/31/2022 | 586 | 130 | -108 | 180 | N/A |
9/30/2022 | 548 | 137 | -119 | 152 | N/A |
6/30/2022 | 509 | 143 | -129 | 124 | N/A |
3/31/2022 | 487 | 143 | -180 | 98 | N/A |
12/31/2021 | 465 | 143 | -230 | 73 | N/A |
9/30/2021 | 416 | 124 | -183 | 73 | N/A |
6/30/2021 | 367 | 105 | -135 | 73 | N/A |
3/31/2021 | 363 | 113 | -65 | 84 | N/A |
12/31/2020 | 358 | 121 | 6 | 96 | N/A |
9/30/2020 | 341 | 121 | N/A | N/A | N/A |
6/30/2020 | 323 | 120 | N/A | N/A | N/A |
3/31/2020 | 305 | 110 | N/A | N/A | N/A |
12/31/2019 | 286 | 100 | 18 | 92 | N/A |
12/31/2018 | 203 | 58 | 21 | 66 | N/A |
12/31/2017 | 138 | 41 | N/A | 39 | N/A |
12/31/2016 | 106 | 34 | N/A | 39 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1501's forecast earnings growth (27.2% per year) is above the savings rate (2.3%).
Earnings vs Market: 1501's earnings (27.2% per year) are forecast to grow faster than the Hong Kong market (10.8% per year).
High Growth Earnings: 1501's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1501's revenue (28.7% per year) is forecast to grow faster than the Hong Kong market (7.5% per year).
High Growth Revenue: 1501's revenue (28.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1501's Return on Equity is forecast to be low in 3 years time (14.7%).